New Releases from NCBI BookshelfPertuzumab: Therapeutic area: Early-stage breast cancer: Reimbursement Review [Internet].​Pertuzumab: Therapeutic area: Early-stage breast cancer: Reimbursement Review [Internet].

By /

HER2-positive breast cancer is a subtype of breast cancer characterized by overexpression of the HER2 protein, which is associated with more aggressive disease and a higher risk of recurrence.

​ 

Leave a Comment

Your email address will not be published. Required fields are marked *

Useful Links

NEWREDMARS SKILL AND RESEARCH        FOUNDATION

Registration No: 771800548      Contact Number : +91-8249516996

©2021-2024. Newredmars Skill and Research Foundation. All Rights Reserved.

Scroll to Top